Skip to content
IceCure
DISTRIBUTORS
INVESTORS
  • Media
    • News
    • Events
    • Presentations
Menu
  • Media
    • News
    • Events
    • Presentations
U.S
INTERNATIONAL

You are now in the International site

  • Home
  • Company
    • About Us
    • Careers
  • Prosense System
    • User Manuals
  • Professionals
    • Breast Care
    • Interventional Radiology
    • ICE3 Trial
    • Fibroadenomas
    • Testimonials
    • Resources
  • Patients
    • Frequently Asked Questions
  • Contact Us
Menu
  • Home
  • Company
    • About Us
    • Careers
  • Prosense System
    • User Manuals
  • Professionals
    • Breast Care
    • Interventional Radiology
    • ICE3 Trial
    • Fibroadenomas
    • Testimonials
    • Resources
  • Patients
    • Frequently Asked Questions
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Results
  • Share Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Events & Presentations
  • Email Alerts
Jul 05, 2022 8:00am EDT

Former Itamar Medical CEO & President Gilad Glick Joins IceCure Medical as a Strategic Advisor for Global Go-To-Market Operations

Jul 04, 2022 2:30pm EDT

Tracking News - More Details of Marketing Progress for IceSense3™ in Mainland China

Jun 15, 2022 8:00am EDT

IceCure's ProSense® Featured at SIR 2022 Annual Meeting in Breast Cancer Cryoablation Categorical Course

Jun 13, 2022 8:00am EDT

IceCure Medical, Shanghai Medtronic & Turing Medical Sign Distribution Agreement in Mainland China

Jun 09, 2022 8:00am EDT

IceCure Medical's ProSense® Cryoablation System Submitted for Regulatory Approval in Brazil

May 18, 2022 7:00am EDT

IceCure Medical Reports First Quarter 2022 Financial Results and Operational Highlights

May 11, 2022 2:09pm EDT

IceCure Medical to Report Q1 2022 Results and Conduct Conference Call May 18, 2022

Apr 27, 2022 9:00am EDT

IceCure Medical Presents ICE3 Breast Cancer Trial Interim Data, Hosts Cryoablation Symposium & Conducts Hands-On ProSense® Training Sessions at the European Conference on Interventional Oncology

Jan 31, 2022 8:00am EST

IceCure Medical Announces Preliminary Unaudited 2021 Year-End Financial Results

Jan 05, 2022 8:00am EST

IceCure Medical CEO Issues Letter to Shareholders

  • 1
  • 2
  • 3
  • 4
  • 5
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
IceCure

IceCure Medical E: icecuresupport@icecure-medical.com
HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

PRIVACY POLICY | TERMS & CONDITIONS

Last Updated November 23, 2021

Facebook Twitter Linkedin Youtube

HOME

COMPANY

  • About Us
  • Careers
Menu
  • About Us
  • Careers

PROSENSE SYSTEM

PROFESSIONALS

  • Breast Care
  • Interventional Radiology
  • ICE3 Trial
  • Fibroadenomas
  • Testimonials
Menu
  • Breast Care
  • Interventional Radiology
  • ICE3 Trial
  • Fibroadenomas
  • Testimonials

PATIENTS

  • Frequently Asked Questions
Menu
  • Frequently Asked Questions

CONTACT US

Copyright IceCure Medical © 2022
Scroll to the top of the page